Welcome!
Acumen Diagnostics
Company in the news
Q&M to suspend Acumen’s laboratory business
The move comes after Acumen's clinical laboratory service licence expired on Sept 15.
October 28, 2024
Company in the news
Acumen CEO placed on leave of absence due to acquisition of indirect interest in assets of Acumen’s supplier
Ong has objected to being placed on a leave of absence as she does not agree that there is any cause for investigation.
June 30, 2024
Broker's Calls
CGS-CIMB updates Q&M to 'add' as Acumen's tender win alleviates short-term pressure
"We believe valuations have turned attractive for Q&M": CGS-CIMB as their FY2023 earnings note negligible contribution from Acumen
October 13, 2022
Corporate moves
Q&M Dental banks on AI tech after Covid-19 high
Q&M is coming off its Covid-19 high, but it intends to ride on another boom.
July 07, 2022
Broker's Calls
CGS-CIMB expects earnings momentum to ease for Q&M; valuation remains attractive
Q&M's earnings growth momentum is expected to ease but at 15.2 times P/E and a dividend yield of 7%, the stock is still attractive
February 11, 2022
Stocks To Watch
Q&M Dental Group: Outlook bright with expansion and a spin-off
Bright smiles ahead for Q&M Dental Group.
January 27, 2022
Broker's Calls
Potential listing of Acumen on Nasdaq may boost Q&M and Aoxin Q&M: UOBKH
Acumen's potential listing on Nasdaq bodes well for both Aoxin Q&M and Q&M Dental.
January 24, 2022
Covid-19
Q&M's Acumen Diagnostics granted MOH Covid-19 offsite PCR testing license
PCR testing services will be rolled out to 10 clinics by Dec 31.
December 16, 2021
Covid-19
Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant
This is in addition to being able to detect Covid-19 cases infected with the Delta variant, says the group.
December 03, 2021
M&A
Aoxin Q&M acquires 49% stake in Q&M's Acumen for $29.4 mil
Q&M, which owns a 32.95% stake in Aoxin Q&M, will have effective ownership of 67.15% in Acumen post-transaction.
October 04, 2021